Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome

Moloney E.D., Evans T.W.

Source: Eur Respir J 2003; 21: 720-727
Journal Issue: April
Disease area: Pulmonary vascular diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Moloney E.D., Evans T.W.. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur Respir J 2003; 21: 720-727

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22
Year: 2002

Acute respiratory failure during pregnancy
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=241
Year: 2006

Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: effects of corticosteroid
Source: Eur Respir J 2002; 20: Suppl. 38, 36s
Year: 2002

Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
Source: Eur Respir Rev, 30 (161) 210059; 10.1183/16000617.0059-2021
Year: 2021



Exogenous pulmonary surfactant combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome
Source: Annual Congress 2007 - Lung recruitment
Year: 2007


The impact of left heart dysfunction in patients with obesity hypoventilation syndrome with acute on chronic respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Differences in pulmonary function tests between acute respiratory distress syndrome of pulmonary and extrapulmonary etiology
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011


Corticosteroids in acute respiratory distress syndrome
Source: Virtual Congress 2021 – Respiratory critical care
Year: 2021


Pulmonary gas-exchange impairments in pulmonary diseases: mechanisms
Source: Annual Congress 2007 - PG2 - Respiratory physiology: pulmonary gas transfer and arterial blood gases
Year: 2007



Current invasive ventilatory strategies in acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=161
Year: 2002

Ventilatory management in acute respiratory failure of patients with obesity-hypoventilation syndrome
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009

Pneumonectomy subjects with acute respiratory distress syndrome: what to do
Source: Eur Respir Rev 2015; 24: 154
Year: 2015


Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021


Noninvasive ventilation in acute lung injury and acute respiratory distress syndrome
Source: Annual Congress 2009 - Controversies of noninvasive ventilation in acute patients
Year: 2009


NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded)
Source: Eur Respir Mon; 2008: 41: 60–71
Year: 2008

Corticosteroids and acute respiratory distress syndrome (ARDS)
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007


Management of acute exacerbation of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=387
Year: 2006

Surfactant therapy in acute lung injury/acute respiratory distress syndrome
Source: Eur Respir Mon 2012; 55: 54-64
Year: 2012